Ambrx Biopharma, Inc.
SEC Filing List
AMAM CIK: 0001990550
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SC 13G/A | Amendment to Schedule filed to report ac... | Deep Track Capital, Lp | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 11/14/2024 | |
| 15-12G | Notice of termination of registration of... | Ambrx Biopharma, Inc. | CRAVATH SWAINE & MOORE 01/FA /fa | 03/18/2024 | |
| 8-K | Current report filing | Ambrx Biopharma, Inc. | CRAVATH SWAINE & MOORE 01/FA /fa | 03/12/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ambrx Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/08/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ambrx Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/08/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ambrx Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/08/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ambrx Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/08/2024 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 03/08/2024 | ||
| S-8 POS | Post-effective amendment to a S-8 regist... | Ambrx Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/08/2024 | |
| 4 | Statement of changes in beneficial owner... | Aromando Andrew | DONNELLEY FINANCIAL SOLUTIONS /fa | 03/07/2024 | |
| No record found. | |||||
| Load More | |||||
